Annals of Internal Medicine

publication venue for

Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study. 169:732-732. 2018
Annals On Call - Glycemic Control in Type 2 Diabetes: How Low Should We Go?. 169:OC1-OC1. 2018
Review: In adults with type 1 diabetes, SGLT-2 inhibitors reduce HbA1c but increase diabetic ketoacidosis. 169:JC3-JC3. 2018
Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors. 169:JC2-JC2. 2018
In hospitalized adults with polypharmacy, a multifaceted pharmacist intervention reduced readmissions at 180 days. 168:JC59-JC59. 2018
Review: Adding a DPP-4 inhibitor to an SGLT-2 inhibitor reduces genital, but not genitourinary, tract infections. 168:JC33-JC33. 2018
Review: Multilevel and patient-level implementation strategies reduce BP more than usual care in hypertension. 168:JC29-JC29. 2018
Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery. 168:237-237. 2018
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms. 168:JC23-JC23. 2018
Prognostic Accuracy of the Quick Sequential Organ Failure Assessment for Mortality in Patients With Suspected Infection. 168:266-266. 2018
Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas. 168:JC8-JC8. 2018
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. 169:467-473. 2018
After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy. 167:JC70-JC70. 2017
Review: In HF with preserved EF, β-blockers reduced mortality; drug treatment overall did not. 167:JC68-JC68. 2017
In localized prostate cancer, radical prostatectomy and observation did not differ for mortality at 13 years. 167:JC53-JC53. 2017
Your Money or Your Patient's Life? Ransomware and Electronic Health Records. 167:587-587. 2017
4 hs-cTnI algorithms had high sensitivity and low failure rates for ruling out acute MI in the ED. 167:JC35-JC35. 2017
HERDOO2 identified women at low risk for recurrence after 5 to 12 mo of anticoagulation for a first unprovoked VTE. 167:JC33-JC33. 2017
High-STEACS Algorithm missed fewer patients with acute MI than the ESC Pathway in the ED. 167:JC34-JC34. 2017
In knee OA, intraarticular triamcinolone increased cartilage loss and did not differ from saline for knee pain. 167:JC27-JC27. 2017
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism. 167:410-410. 2017
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer. 167:341-341. 2017
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding. 167:JC17-JC17. 2017
In older adults with subclinical hypothyroidism, levothyroxine did not improve symptoms or tiredness. 167:JC14-JC14. 2017
Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia. 167:170-170. 2017
Computer-Aided Systematic Review Screening Comes of Age. 167:210-210. 2017
Guidelines to Limit Added Sugar Intake. 167:219-219. 2017
The Scientific Basis of Guideline Recommendations on Sugar Intake. 167:219-219. 2017
Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets. 167:JC10-JC10. 2017
In patients receiving DAPT after coronary stents, the PRECISE-DAPT score predicted bleeding moderately well. 167:JC11-JC11. 2017
In severe aortic stenosis with intermediate surgical risk, TAVR was noninferior to SAVR for death or disabling stroke. 166:JC68-JC68. 2017
Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality. 166:JC70-JC70. 2017
Does Knowledge of the Coronary Anatomy Save Lives in Patients With Unstable Angina?. 166:848-848. 2017
Guideline: In type 2 diabetes, ACP recommends metformin monotherapy if drugs are needed for glycemic control. 166:JC39-JC39. 2017
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding. 166:JC29-JC29. 2017
In patients receiving palliative care, risperidone or haloperidol increased delirium symptoms vs placebo. 166:JC32-JC32. 2017
PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased MI and cardiac death after surgery. 166:JC35-JC35. 2017
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. 166:279-279. 2017
The Scientific Basis of Guideline Recommendations on Sugar Intake. 166:257-257. 2017
In older adults with COPD, new opioid use was linked to increased risk for respiratory and all-cause mortality. 166:JC11-JC11. 2017
In patients with severe sepsis, hydrocortisone did not prevent progression to septic shock. 166:JC10-JC10. 2017
Review: Some drugs, added to hydration, prevent contrast-induced acute kidney injury. 166:JC9-JC9. 2017
A reporting tool for practice guidelines in health care: the RIGHT statement. 166:128-132. 2017
Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children. 165:617-617. 2016
Review: In severe aortic stenosis, TAVI and conventional surgery do not differ for ≤ 30-day or ≤ 1-year mortality. 165:JC31-JC31. 2016
Wells Rule andd-Dimer Testing to Rule Out Pulmonary Embolism. 165:253-253. 2016
Adding candesartan-HCTZ to rosuvastatin increased adverse events but not benefits in patients at intermediate CV risk. 165:JC8-JC8. 2016
In insulin-treated type 1 diabetes, canagliflozin increased diabetic ketoacidosis. 165:JC2-JC2. 2016
Review: In diabetes, benefits of lowering BP depend on baseline BP being 140 mm Hg or more. 164:JC62-JC62. 2016
Principles for Disclosure of Interests and Management of Conflicts in Guidelines: Desirable and Undesirable Action and Consequences. 164:702-702. 2016
Testosterone gel improved sexual function, but not walk distance or fatigue, in older men with low testosterone. 164:JC56-JC56. 2016
Transition care with telemonitoring did not reduce readmission after hospitalization for heart failure. 164:JC59-JC59. 2016
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia. 164:636-636. 2016
Evidence-Based Guideline: ACR made 10 strong treatment recommendations for RA, but high-quality evidence was sparse. 164:JC27-JC27. 2016
Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF. 164:JC33-JC33. 2016
In older adults with treatment-resistant depression, adding aripiprazole to venlafaxine increased remission at 12 wk. 164:JC10-JC10. 2016
The Triumph of Innovation and the Hard Work of Caring for Patients With Diabetes. 164:127-127. 2016
Content, Consistency, and Quality of Black Box Warnings: Time for a Change. 163:875-875. 2015
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia. 163:519-519. 2015
Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines. 163:548-548. 2015
Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012. 163:482-482. 2015
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality. 163:409-409. 2015
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society. 163:382-382. 2015
Baseline plus 1-hour high-sensitivity cardiac troponin T improved early rule-out and rule-in of acute MI. 163:JC12-JC12. 2015
Baseline plus 1-hour high-sensitivity cardiac troponin T improved early rule-out and rule-in of acute MI. 163:JC12-JC12. 2015
In Memoriam: David Lawrence Sackett, MD, MSc (Epidemiology), 1934–2015. 163:JC2-JC2. 2015
Personalizing Death in the Intensive Care Unit: The 3 Wishes Project. 163:271-271. 2015
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement. 163:118-118. 2015
Use of long-acting, vs short-acting, opioids for chronic pain was linked to unintentional overdose. 163:JC11-JC11. 2015
In hospitalized patients, an electronic alert for acute kidney injury did not differ from usual care. 162:JC6-JC6. 2015
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. 162:777-777. 2015
In acute ischemic stroke, early intraarterial treatment plus usual care improved functional independence. 162:JC2-JC2. 2015
In acute ischemic stroke, rapid intraarterial treatment plus usual care improved functional independence. 162:JC3-JC3. 2015
In ischemic stroke, early intraarterial treatment plus alteplase improved reperfusion and functional outcome. 162:JC4-JC4. 2015
In type 1 diabetes, intensive insulin therapy for 6.5 y reduced mortality at 27 y compared with usual care. 162:JC12-JC12. 2015
Review: In peri- or postmenopausal women, DHEA does not improve symptoms and increases androgenic side effects. 162:JC9-JC9. 2015
d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism. 162:671-671. 2015
In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD. 162:JC11-JC11. 2015
Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation. 162:JC4-JC4. 2015
Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants. 162:JC3-JC3. 2015
Cervical Spine Clearance in Obtunded Patients After Blunt Traumatic Injury. 162:429-429. 2015
Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events. 162:JC9-JC9. 2015
Albumin Administration in Patients With Sepsis. 162:319-319. 2015
In suspected nephrolithiasis, US did not differ from CT for high-risk diagnoses but reduced radiation exposure. 162:JC4-JC4. 2015
Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1cwithout increasing hypoglycemia. 162:JC6-JC6. 2015
d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy. 162:27-27. 2015
The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. 163:S1-S40. 2015
Comparison of Community Health Worker–Led Diabetes Medication Decision-Making Support for Low-Income Latino and African American Adults With Diabetes Using E-Health Tools Versus Print Materials. 161:S13-S13. 2014
Pharmacologic Interventions for Painful Diabetic Neuropathy. 161:639-639. 2014
Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding. 161:JC9-JC9. 2014
Fluid Resuscitation in Sepsis. 161:347-347. 2014
Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults. 161:242-242. 2014
Bariatric surgery improved HbA1cmore than intensive medical therapy in obese patients with uncontrolled type 2 DM. 161:JC4-JC4. 2014
Methotrexate reduced pain and improved function in symptomatic knee osteoarthritis. 161:JC6-JC6. 2014
Review: Natriuretic peptide–guided therapy reduces mortality more than clinically guided therapy in heart failure. 161:JC10-JC10. 2014
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age. 160:JC7-JC7. 2014
Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non–ST-elevation ACS. 160:JC9-JC9. 2014
In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2and CHA2DS2-VASc. 160:JC13-JC13. 2014
Live kidney donation was associated with increased mortality and end-stage renal disease at 15 years. 160:JC12-JC12. 2014
Review: Calprotectin testing differentiates inflammatory bowel disease from the irritable bowel syndrome. 160:JC13-JC13. 2014
Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria. 160:JC3-JC3. 2014
Review: New oral anticoagulants increase GI bleeding in venous thrombosis and ACS. 160:JC4-JC4. 2014
Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation. 160:JC3-JC3. 2014
Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline. 160:182-189. 2014
Methylprednisolone injections reduced carpal tunnel syndrome symptoms at 10 weeks and surgery at 1 year. 160:JC11-JC11. 2014
Review: In type 2 diabetes, dipeptidyl peptidase-4 inhibitors do not increase pancreatitis. 160:JC8-JC8. 2014
In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke.. 161:JC8-JC8. 2014
In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding. 161:JC9-JC9. 2014
Crohn disease was not associated with increased risk for mortality. 159:JC12-JC12. 2013
Statin Toxicity From Macrolide Antibiotic Coprescription. 159:575-575. 2013
Intermittent pneumatic compression reduced deep venous thrombosis after stroke. 159:JC3-JC3. 2013
Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic stroke. 159:JC4-JC4. 2013
Review: Treatment options for asymptomatic carotid artery stenosis were compared. 159:JC6-JC6. 2013
Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit. 159:JC9-JC9. 2013
Statin Toxicity From Macrolide Antibiotic Coprescription. 158:869-869. 2013
Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty. 158:800-800. 2013
Review: Blood transfusions are associated with higher mortality than no or restricted transfusions in MI. 158:JC13-JC13. 2013
Probiotics for the Prevention ofClostridium difficile–Associated Diarrhea. 158:706-706. 2013
Adding renal dysfunction to CHADS2did not improve prediction of stroke or systemic embolism in AF. 158:JC13-JC13. 2013
Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults. 158:447-447. 2013
Review: Case management reduces mortality and HF readmissions in patients with HF. 158:JC11-JC11. 2013
Selectived-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis. 158:93-93. 2013
Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit. 159:JC9-JC9. 2013
Probiotics for the Prevention ofClostridium difficile–Associated Diarrhea. 157:878-878. 2012
rt-PA within 6 hours of acute ischemic stroke did not improve clinical outcomes at 6 months. 157:JC5-JC5. 2012
Screening Women for Intimate Partner Violence. 157:676-676. 2012
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes. 157:JC4-JC4. 2012
Review: Oseltamivir relieves symptoms but does not reduce hospitalizations in influenza. 157:JC3-JC3. 2012
Antivirals for Treatment of Influenza. 157:386-386. 2012
Effects of Excessive Fructose Intake on Health. 156:905-905. 2012
Effects of Excessive Fructose Intake on Health. 156:905-905. 2012
Hypnotic drugs were associated with increased risk for mortality. 156:JC6-JC6. 2012
Review: Perioperative statins reduce perioperative MI and AF in statin-naïve patients. 156:JC6-JC6. 2012
Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines. 156:809-809. 2012
IV salbutamol increased mortality in patients with the acute respiratory distress syndrome. 156:JC5-JC5. 2012
Inviting Patients to Read Doctors' Notes. 156:608-608. 2012
Effect of Fructose on Body Weight in Controlled Feeding Trials. 156:291-291. 2012
Effects of School Closure on Incidence of Pandemic Influenza in Alberta, Canada. 156:173-173. 2012
Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database. 156:195-195. 2012
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. 156:512-524. 2012
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. 156:710-719. 2012
Correction: Whole-Body Vibration. 155:860-860. 2011
Effect of 12 Months of Whole-Body Vibration Therapy on Bone Density and Structure in Postmenopausal Women. 155:668-668. 2011
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial. 155:660-660. 2011
Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios. 155:653-653. 2011
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable. 155:579-579. 2011
Outpatient treatment was noninferior to inpatient treatment for preventing recurrent VTE in low-risk patients with acute PE. 155:JC4-JC4. 2011
Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery. 155:477-477. 2011
Annual screening with CA-125 and transvaginal ultrasonography did not reduce ovarian cancer incidence or mortality. 155:JC3-JC3. 2011
Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda. 155:209-209. 2011
Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints. 155:JC2-JC2. 2011
Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. 155:179-179. 2011
The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 154:JC6-JC6. 2011
Rates of Kidney Transplantation in Nations With Presumed Consent. 154:778-778. 2011
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions. 154:JC5-JC5. 2011
Assessment of Recurrence Risk After Unprovoked Venous Thromboembolism. 154:644-644. 2011
Cholera Epidemic in Haiti, 2010: Using a Transmission Model to Explain Spatial Spread of Disease and Identify Optimal Control Interventions. 154:593-593. 2011
Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery. 154:523-523. 2011
Should Patients With Stroke Wear Compression Stockings?. 154:506-506. 2011
Update in Hematology and Oncology: Evidence Published in 2010. 154:487-487. 2011
Hormone therapy increased risk for kidney stones in healthy postmenopausal women. 154:JC3-JC3. 2011
Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk. 154:310-310. 2011
Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease. 153:JC5-JC5. 2010
Informing the Debate: Rates of Kidney Transplantation in Nations With Presumed Consent. 153:641-641. 2010
Informing the Debate: Rates of Kidney Transplantation in Nations With Presumed Consent. 153:641-649. 2010
Should Patients With Stroke Wear Compression Stockings to Prevent Venous Thromboembolism?. 153:610-610. 2010
A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 153:JC4-JC4. 2010
Individual and combined confrontation visual field tests performed poorly as a screen for visual field abnormalities. 153:JC4-JC4. 2010
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism. 153:523-523. 2010
What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials. 153:532-532. 2010
Lenient rate control is as effective as strict rate control for preventing cardiovascular events in AF. 153:JC2-JC2. 2010
Systematic Review: Factors Associated With Risk for and Possible Prevention of Cognitive Decline in Later Life. 153:182-182. 2010
Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility. 153:8-8. 2010
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease. 153:23-23. 2010
Review: Evidence on the effectiveness of sodium bicarbonate regimens to prevent contrast-induced nephropathy is unclear. 152:JC5-JC5. 2010
On-demand ordering of chest radiographs reduced the number of chest radiographs in mechanically ventilated adults. 152:JC3-JC3. 2010
Risk for postoperative venous thromboembolism in women was increased for ≥ 12 weeks and varied by type of surgery. 152:JC3-JC3. 2010
Adding revascularization to medical therapy did not improve renal function in atherosclerotic renal artery stenosis. 152:JC2-JC2. 2010
Either cholesterol or apolipoprotein levels can be used to determine risk for CVD; triglycerides are not useful. 152:JC2-JC2. 2010
Prediction Rules Must Be Developed According to Methodological Guidelines. 152:263-263. 2010
Review: Neuraminidase inhibitors relieve influenza symptoms and reduce laboratory-confirmed influenza in healthy adults. 152:JC2-JC2. 2010
Glatiramer acetate delayed conversion to multiple sclerosis in patients with clinically isolated syndrome. 152:JC1-JC1. 2010
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding. 152:101-101. 2010
Guidelines and Conflicts of Interest. 153:422-422. 2010
The vexing problem of guidelines and conflict of interest: a potential solution. 152:738-741. 2010
A Mediterranean-style diet reduced need for glucose-lowering drugs more than a low-fat diet in type 2 diabetes. 151:JC6-JC6. 2009
New and underutilized features of ACP Journal Club PLUS and ACPJC.org: stellar articles, searches, and succinct synopses of the principles and practice of “personalized” evidence-based medicine. 151:JC6-JC6. 2009
Sensitive cardiac troponin assays were more accurate than a standard troponin assay for early diagnosis of AMI. 151:JC6-JC6. 2009
Systematic Review: Family History in Risk Assessment for Common Diseases. 151:878-878. 2009
Systematic review: family history in risk assessment for common diseases.. 151:878-885. 2009
Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation. 151. 2009
Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation. 151:JC5-JC5. 2009
The tough math of evidence-based health care: E × KT2 = ROI. 151:JC5-JC5. 2009
Correction: Predicting Deep Venous Thrombosis in Pregnancy. 151:516-516. 2009
Redundant Data in the Meta-analysis onHelicobacter pyloriEradication. 151:513-513. 2009
3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk for stroke after TIA. 151. 2009
Accessing preappraised evidence: fine-tuning the 5S model into a 6S model. 151. 2009
Accessing preappraised evidence: fine-tuning the 5S model into a 6S model. 151:JC3-JC3. 2009
Review: 3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk for stroke after TIA. 151:JC3-JC3. 2009
Vitamin K to Correct Overanticoagulation. 151:435-435. 2009
Comparing the USPSTF and GRADE Approaches to Recommendations. 151:363-363. 2009
Positron Emission Tomography in Staging Early Lung Cancer. 151:221-221. 2009
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. 151:264-264. 2009
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. 151:W-W. 2009
Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?. 151:85-85. 2009
Effect of Telmisartan on Renal Outcomes. 151:1-1. 2009
“Pragmatic” clinical trials: from whose perspective?. 150:JC6-JC6. 2009
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?. 150:803-803. 2009
Composite Outcomes Can Distort the Nature and Magnitude of Treatment Benefits in Clinical Trials. 150:566-566. 2009
Aspirin for Prevention and Treatment of Cardiovascular Disease. 150:414-414. 2009
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding. 150:379-379. 2009
Prednisolone, but not valacyclovir, reduced time to complete recovery of facial-nerve function in Bell palsy. 150:JC3-JC3. 2009
What does it take to put an ugly fact through the heart of a beautiful hypothesis?. 150:JC3-JC3. 2009
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin. 150:293-293. 2009
Is Too Much Intervention Recommended in the ACP Osteoporosis Treatment Guidelines?. 150:285-285. 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular events. 150:JC2-JC2. 2009
Rosuvastatin prevented major cardiovascular events in persons with elevated C-reactive protein. 150:JC1-JC1. 2009
A single measure of urinary neutrophil gelatinase–associated lipocalin was accurate for diagnosing acute kidney injury. 149:JC6-JC6. 2008
GRADE: assessing the quality of evidence for diagnostic recommendations. 149:JC6-JC6. 2008
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis. 149:698-698. 2008
Evidence in context: One person's poison is another's acceptable risk. 149:JC5-JC5. 2008
Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-analyses. 149:596-596. 2008
Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism. 149:481-481. 2008
Intensive glucose control did not prevent important complications in type 2 diabetes. 149:JC3-JC3. 2008
Intensive glucose control increased mortality and did not prevent cardiovascular events in type 2 diabetes. 149:JC3-JC3. 2008
The Importance of Measuring Executive Function When Studying the Effects of Cognition-Enhancing Agents. 149:359-359. 2008
Prognosis after West Nile Virus Infection. 149:232-232. 2008
Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients. 149:JC2-JC2. 2008
Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses. 149:219-219. 2008
Age, sex, and functional impairment predicted risk for mortality in incident dementia at 14 years. 149:JC1-JC1. 2008
Evidence-based medicine targets the individual patient. Part 2: Guides and tools for individual decision-making. 149:JC1-JC1. 2008
Evidence-based medicine targets the individual patient. Part 1: How clinicians can use study results to determine optimal individual care. 148:JC4-JC4. 2008
Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis. 148:JC4-JC4. 2008
Low-dose hydrocortisone did not improve survival in patients with septic shock but reversed shock earlier. 148:JC4-JC4. 2008
Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease. 148:JC4-JC4. 2008
Guideline Adaptation: An Appealing Alternative to De Novo Guideline Development. 148:563-563. 2008
Guideline Adaptation: An Appealing Alternative to De Novo Guideline Development. 148:564-564. 2008
d-Dimer Testing in Pregnancy: Clinically Useful, but at What Cost?. 148:484-484. 2008
Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians. 148:370-370. 2008
Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline. 148:379-379. 2008
The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism. 147:766-766. 2007
Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin. 147:671-671. 2007
Anticoagulant Prophylaxis for Hospitalized Medical Patients. 147:524-524. 2007
Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection. 147:400-400. 2007
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes. 147:304-304. 2007
Rituximab for Patients with Idiopathic Thrombocytopenic Purpura. 147:281-281. 2007
A Red Blood Cell Agglutination d-Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy. 147:165-165. 2007
Ethical Issues in Stopping Randomized Trials Early Because of Apparent Benefit. 146:878-878. 2007
When My Father Died. 146:893-893. 2007
Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism. 146:761-761. 2007
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients. 146:278-278. 2007
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin. 146:184-184. 2007
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura. 146:25-25. 2007
Interval versus Continuous High-Intensity Exercise in Chronic Obstructive Pulmonary Disease. 145:816-816. 2006
Meta-Analysis: Risk for Hypertension in Living Kidney Donors. 145:185-185. 2006
An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism. 144:812-812. 2006
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency. 144:673-673. 2006
Plasma Exchange When Myeloma Presents as Acute Renal Failure. 143:777-777. 2005
Use of a Clinical Prediction Score in Patients with Suspected Deep Venous Thrombosis: Two Steps Forward, One Step Back?. 143:140-140. 2005
Clinical Experience and Quality of Health Care. 143:85-85. 2005
Challenges in Systematic Reviews That Evaluate Drug Efficacy or Effectiveness. 142:1066-1066. 2005
Challenges in systematic reviews that evaluate drug efficacy or effectiveness. 142:1066-1072. 2005
A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d-Dimer Testing Compared with Repeated Ultrasonography. 142:490-490. 2005
Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death. 142:510-510. 2005
Decisions about Treating Community-Acquired Pneumonia. 142:215-215. 2005
Glycemia and Risk for Cardiovascular Disease. 142:227-227. 2005
Glycemia and Risk for Cardiovascular Disease. 142:227-227. 2005
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation. 141:653-653. 2004
Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor. 141:475-475. 2004
Low-Molecular-Weight Heparin for Pulmonary Embolism. 141:407-407. 2004
Low-Molecular-Weight Heparin for Pulmonary Embolism. 141:407-407. 2004
Evidence-Based Clinical Practice Guideline for the Prevention of Ventilator-Associated Pneumonia. 141:305-305. 2004
Routine Stocking Therapy after Deep Venous Thrombosis: A Clinical Dilemma. 141:314-314. 2004
Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. 141:80-80. 2004
Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study. 140:857-857. 2004
Suboptimal Monitoring and Dosing of Unfractionated Heparin. 140:582-582. 2004
Randomized Trial of Warfarin Nomograms. 140:490-490. 2004
Randomized trial of warfarin nomograms.. 140:490-491. 2004
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism. 140:175-175. 2004
Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism. 139:893-893. 2003
Which Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Benefit from Noninvasive Positive-Pressure Ventilation?. 138:861-861. 2003
A Diagnostic Strategy Involving a Quantitative Latex d-Dimer Assay Reliably Excludes Deep Venous Thrombosis. 138:787-787. 2003
Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin. 138:720-720. 2003
Oral Vitamin K for Warfarin-Associated Coagulopathy. 138:611-611. 2003
Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System. 138:128-128. 2003
Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty. 137:648-648. 2002
Clinical Assessment and D-dimer Testing in Deep Venous Thrombosis. 137:371-371. 2002
Colloid Use in the Critically Ill. 137:370-370. 2002
Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy. 137:251-251. 2002
Questioning the Treatment of Venous Thromboembolism. 137:145-145. 2002
Cardiovascular Outcomes and Renal Disease. 136:633-633. 2002
Cardiovascular Outcomes and Renal Disease. 136:634-634. 2002
Long-Term Prediction of Coronary Heart Disease in Young Men. 136:631-631. 2002
The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative. 136:619-619. 2002
Helicobacter pylori Eradication Therapy for Nonulcer Dyspepsia. 136:555-555. 2002
Chemotherapy for Older Patients with Newly Diagnosed, Advanced-Stage, Aggressive-Histology Non-Hodgkin Lymphoma. 136:144-144. 2002
Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis. 135:589-589. 2001
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis. 135:502-502. 2001
Colloid Use for Fluid Resuscitation: Evidence and Spin. 135:205-205. 2001
Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and d-dimer Testing. 135:108-108. 2001
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial. 134:629-629. 2001
Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective. 134:409-409. 2001
Erythropoietin with Iron Supplementation To Prevent Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty. 133:845-845. 2000
Effect of a Preoperative Intervention on Preoperative and Postoperative Outcomes in Low-Risk Patients Awaiting Elective Coronary Artery Bypass Graft Surgery. 133:253-253. 2000
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement. 132:853-853. 2000
Homocyst(e)ine and Cardiovascular Disease. 132:676-676. 2000
Use of Statins and Fibrates in Hyperlipidemic Patients with Neuromuscular Disorders. 132:418-418. 2000
Helical Computed Tomography and the Diagnosis of Pulmonary Embolism. 132:240-240. 2000
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism (vol 129, pg 1006, 1998). 132:247-247. 2000
Systemic Amyloidosis Presenting with Angina Pectoris. 131:838-838. 1999
Interpreting, Integrating, and Individualizing Evidence about the Prevention of Diabetic Nephropathy. 131:707-707. 1999
Clinical Model for Management of Pulmonary Embolism. 131:475-475. 1999
Clinical Utility of a Rapid Whole-Blood d-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis. 131:417-417. 1999
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence. 131:363-363. 1999
Ventilator-Associated Pneumonia in Critically Ill Patients. 130:1028-1028. 1999
Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism. 129:1006-1006. 1998
The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism. 129:1044-1044. 1998
Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism. 129:997-997. 1998
Transesophageal Echocardiography: Useful Tool or Expensive Toy?. 129:748-748. 1998
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients. 129:433-433. 1998
The Ineffectiveness of Immunosuppressive Therapy in Lymphocytic Myocarditis: An Overview. 129:317-317. 1998
Coenzyme A Reductase Inhibitors and Stroke. 129:162-162. 1998
Noninvasive Diagnosis of Deep Venous Thrombosis. 128:663-663. 1998
Locating and Appraising Systematic Reviews. 128:323-323. 1998
Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery. 128:270-270. 1998
Effect of HMGcoA Reductase Inhibitors on Stroke. 128:89-89. 1998
The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia. 127:804-804. 1997
Selecting and Appraising Studies for a Systematic Review. 127:531-531. 1997
Antileukotrienes in the Treatment of Asthma. 127:472-472. 1997
Reply: Warfarin: Less May Be Better. 127:333-333. 1997
The Relation between Systematic Reviews and Practice Guidelines. 127:210-210. 1997
Splenectomy for Relapsing Thrombotic Thrombocytopenic Purpura. 126:915-915. 1997
Intravenous Iron and Erythropoietin for Anemia Associated with Crohn Disease. 126:782-782. 1997
Locating and Appraising Systematic Reviews. 126:532-532. 1997
Dietary Calcium and Blood Pressure. 126:492-492. 1997
Systematic Reviews: Critical Links in the Great Chain of Evidence. 126:389-389. 1997
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions. 126:376-376. 1997
Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel.. 126:319-326. 1997
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy. 126:133-133. 1997
Splenectomy Done during Hematologic Remission To Prevent Relapse in Patients with Thrombotic Thrombocytopenic Purpura. 125:294-294. 1996
The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data (vol 123, pg 860, 1995). 124:934-934. 1996
Once-Daily Aminoglycoside Dosing in Immunocompetent Adults. 124:717-717. 1996
The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data. 123:860-860. 1995
Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal Bleeding. 123:280-280. 1995
Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura. 122:569-569. 1995
Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery. 122:47-47. 1995
Interactions of Warfarin with Drugs and Food. 121:676-676. 1994
Analyzing Computer-based Decision Support Systems. 121:469-469. 1994
Can Bruits Distinguish High-Grade from Moderate Symptomatic Carotid Stenosis?. 120:633-633. 1994
Can bruits distinguish high-grade from moderate symptomatic carotid stenosis? The North American Symptomatic Carotid Endarterectomy Trial.. 120:633-637. 1994
Glycogen Storage Disease in Adults. 120:218-218. 1994
Effects of Computer-based Clinical Decision Support Systems on Clinician Performance and Patient Outcome: A Critical Appraisal of Research. 120:135-135. 1994
MONITORING HEPARIN-THERAPY - RESPONSE. 120:170-170. 1994
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty. 119:1105-1105. 1993
Screening for Abdominal Aortic Aneurysm in Men Ages 60 to 80 Years: A Cost-Effectiveness Analysis. 119:411-411. 1993
Impedance Plethysmography and DVT Diagnosis. 119:246-246. 1993
Establishing a Therapeutic Range for Heparin Therapy. 119:104-104. 1993
Measuring Health-Related Quality of Life. 118:622-622. 1993
Incidence of Postpartum Thyroid Dysfunction in Patients with Type I Diabetes Mellitus. 118:419-419. 1993
Eliciting Patient Preferences. 118:76-76. 1993
Limitations of Impedance Plethysmography in the Diagnosis of Clinically Suspected Deep-Vein Thrombosis. 118:25-25. 1993
THROMBOSIS IN ANTITHROMBIN-III DEFICIENCY - REPLY. 117:875-875. 1992
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. 117:353-353. 1992
Subcutaneous compared with intravenous heparin for deep vein thrombosis.. 117:266. 1992
A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer. 117:53-53. 1992
SUBGROUP ANALYSES - RESPONSE. 117:93-94. 1992
Splenic Radiation for Corticosteroid-resistant Immune Thrombocytopenia. 116:977-977. 1992
Failure of Aspirin plus Dipyridamole To Prevent Restenosis after Carotid Endarterectomy. 116:731-731. 1992
Thrombosis in Antithrombin-III-deficient Persons. 116:754-754. 1992
CLINICAL-TRIALS - TO TERMINATE OR NOT TO TERMINATE - REPLY. 116:700-700. 1992
A Consumer's Guide to Subgroup Analyses. 116:78-78. 1992
How Should Results from Completed Studies Influence Ongoing Clinical Trials?. 115:818-818. 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation. 115:727-727. 1991
LOW-MOLECULAR-WEIGHT HEPARIN FOR DEEP-VEIN THROMBOSIS. 115:232-232. 1991
Prevention of Deep Vein Thrombosis after Elective Hip Surgery. 114:545-545. 1991
Loose Connections between Peer-Reviewed Clinical Journals and Clinical Practice. 113:724-724. 1990
STRUCTURED ABSTRACTS - RESPONSE. 113:722-723. 1990
More Informative Abstracts Revisited. 113:69-69. 1990
Deep Vein Thrombosis and Duplex Ultrasound. 112:307-307. 1990
Then-of-1 Randomized Controlled Trial: Clinical Usefulness. 112:293-293. 1990
Online Access to MEDLINE in Clinical Settings. 112:78-78. 1990
MEDICAL THERAPY FOR CHRONIC CONGESTIVE HEART-FAILURE - REPLY. 111:768-769. 1989
Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature?. 111:1-1. 1989
Medical Therapy for Chronic Congestive Heart Failure. 110:758-758. 1989
Methotrexate in Rheumatoid Arthritis. 110:581-581. 1989
Screening for Endometrial Cancer: Is It Effective?. 110:177-177. 1989
Pulmonary Hypertension in Hemophilia. 109:759-759. 1988
Somatostatin Treatment for Cryptosporidial Diarrhea in a Patient with the Acquired Immunodeficiency Syndrome (AIDS). 108:708-708. 1988
ALTERNATE METHODS OF HEPARIN ADMINISTRATION. 108:306-306. 1988
Increased Neutrophil Elastase Activity in Cigarette Smokers. 107:680-680. 1987
Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis. 107:441-441. 1987
Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer. 107:451-451. 1987
Methotrexate in Rheumatoid Arthritis. 107:358-358. 1987
Bicarbonate in Severe Lactic Acidosis. 107:258-258. 1987
HEPARIN IN ACUTE PARTIAL STABLE STROKE - RESPONSE. 106:782-782. 1987
PAPER CHASE - RESPONSE. 106:783-783. 1987
A proposal for more informative abstracts of clinical articles. Ad Hoc Working Group for Critical Appraisal of the Medical Literature.. 106:598-604. 1987
Correction: How to Keep Up with the Medical Literature. 106:174-174. 1987
Canadian Cancer Care: Organizational Models. 105:932-932. 1986
How to Keep Up with the Medical Literature: VI. How to Store and Retrieve Articles Worth Keeping. 105:978-978. 1986
Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke: A Randomized Controlled Trial. 105:825-825. 1986
Intravenous heparin for the prevention of stroke progression in acute partial stable stroke.. 105:825-828. 1986
How to Keep Up with the Medical Literature: V. Access by Personal Computer to the Medical Literature. 105:810-810. 1986
How to Keep Up with the Medical Literature: IV. Using the Literature to Solve Clinical Problems. 105:636-636. 1986
How to Keep Up with the Medical Literature: III. Expanding the Number of Journals You Read Regularly. 105:474-474. 1986
Searching the Medical Literature. 105:472-472. 1986
How to Keep Up with the Medical Literature: II. Deciding Which Journals to Read Regularly. 105:309-309. 1986
Seroconversion After Hepatitis B Vaccination. 105:293-293. 1986
How to Keep Up with the Medical Literature: I. Why Try to Keep Up and How to Get Started. 105:149-149. 1986
Computer Searching of the Medical Literature. 104:723-723. 1986
COMPUTER SEARCHING OF THE MEDICAL LITERATURE - REPLY. 104:583-583. 1986
ONLINE SYSTEMS FOR SEARCHING MEDLINE - RESPONSE. 104:442-443. 1986
Computer Searching of the Medical Literature. 103:812-812. 1985
Platelet-Aggregating Factor in Thrombotic Thrombocytopenic Purpura. 102:560-560. 1985
Malignant Lymphoma Presenting as Kaposi's Sarcoma in a Homosexual Man with the Acquired Immunodeficiency Syndrome. 102:338-338. 1985
Diagnostic Efficacy of Impedance Plethysmography for Clinically Suspected Deep-Vein Thrombosis. 102:21-21. 1985
Detection of a Platelet-Agglutinating Factor in Thrombotic Thrombocytopenic Purpura. 101:589-589. 1984
Lidocaine Therapy with an Exponentially Declining Infusion. 101:632-632. 1984
Choice of Platelet Anticoagulants. 100:613-613. 1984
Heparin-Associated Thrombocytopenia. 100:535-535. 1984
HEPARIN-ASSOCIATED THROMBOCYTOPENIA - RESPONSE. 101:280-280. 1984
Management of the Pregnant Patient with Idiopathic Thrombocytopenic Purpura. 99:796-796. 1983
Pulmonary Angiography, Ventilation Lung Scanning, and Venography for Clinically Suspected Pulmonary Embolism with Abnormal Perfusion Lung Scan. 98:891-891. 1983
Effect of Digoxin on Right Ventricular Function in Severe Chronic Airflow Obstruction. 95:283-283. 1981
Pheochromocytoma Unmasked by Desipramine Therapy. 94:358-358. 1981
Replacement of Venography in Suspected Venous Thrombosis by Impedance Plethysmography and125I-Fibrinogen Leg Scanning. 94:12-12. 1981
Gentamicin Hemodialysis. 92:709-709. 1980
Tamoxifen and Metastatic Breast Cancer. 89:721-721. 1978
Tamoxifen and Hypercalcemia. 89:423-423. 1978
The Burlington Randomized Trial of the Nurse Practitioner: Health Outcomes of Patients. 80:137-137. 1974
Thrombolytic Therapy and Fatal Pulmonary Emboli. 75:140-140. 1971
Death and Disability in Drug Addiction and Abuse. 67:205-205. 1967
THE MANAGEMENT OF BILIARY TRACT DISORDERS IN PATIENTS WITH HEART DISEASE. 39:484-484. 1953
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding 2003

Annals of Internal Medicine Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)